Current status of inflammasome blockers as anti-inflammatory drugs (Q38011774)

27 August 2017

title

Current status of inflammasome blockers as anti-inflammatory drugs (English)

1 reference

27 August 2017

0 references

1 reference

Gloria López-Castejón

object named as

Gloria López-Castejón

series ordinal

1

0 references

Pablo Pelegrín

object named as

Pablo Pelegrín

series ordinal

2

0 references

language of work or name

English

0 references

publication date

22 May 2012

1 reference

Expert Opinion on Investigational Drugs

27 August 2017

published in

1 reference

27 August 2017

volume

21

1 reference

27 August 2017

issue

7

1 reference

27 August 2017

page(s)

995-1007

1 reference

Toll-like receptors and innate immunity

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Immunological and inflammatory functions of the interleukin-1 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Dynamic regulation of the proinflammatory cytokine, interleukin-1beta: molecular biology for non-molecular biologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

The inflammasome NLRs in immunity, inflammation, and associated diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Inflammatory caspases and inflammasomes: master switches of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

NALP1 in vitiligo-associated multiple autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Pyroptosis: host cell death and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Listeria monocytogenes-infected human peripheral blood mononuclear cells produce IL-1beta, depending on listeriolysin O and NLRP3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Cryopyrin activates the inflammasome in response to toxins and ATP

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Inflammation and fibrosis during Chlamydia pneumoniae infection is regulated by IL-1 and the NLRP3/ASC inflammasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Lack of the purinergic receptor P2X7 results in resistance to contact hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Characterization of a selective and potent antagonist of human P2X(7) receptors, AZ11645373.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Altered cytokine production in mice lacking P2X(7) receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Sphingosine regulates the NLRP3-inflammasome and IL-1β release from macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Pannexin-1 couples to maitotoxin- and nigericin-induced interleukin-1beta release through a dye uptake-independent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

The modern management of gout

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Gout-associated uric acid crystals activate the NALP3 inflammasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Human alveolar macrophage cytokine release in response to in vitro and in vivo asbestos exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Thioredoxin-interacting protein links oxidative stress to inflammasome activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

A role for mitochondria in NLRP3 inflammasome activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Interplay between redox status and inflammasome activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Innate immune detection of bacterial virulence factors via the NLRC4 inflammasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Multiple Nod-like receptors activate caspase 1 during Listeria monocytogenes infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Immune recognition of Pseudomonas aeruginosa mediated by the IPAF/NLRC4 inflammasome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

A NOD2-NALP1 complex mediates caspase-1-dependent IL-1beta secretion in response to Bacillus anthracis infection and muramyl dipeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Intracellular DNA recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

The AIM2 inflammasome is critical for innate immunity to Francisella tularensis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Listeria monocytogenes triggers AIM2-mediated pyroptosis upon infrequent bacteriolysis in the macrophage cytosol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 beta production

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Pyrin levels in human monocytes and monocyte-derived macrophages regulate IL-1beta processing and release

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

COPs and POPs: modulators of inflammasome activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

The emerging role of interleukin-1β in autoinflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Why not treat human cancer with interleukin-1 blockade?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

XOMA 052, an anti-IL-1{beta} monoclonal antibody, improves glucose control and {beta}-cell function in the diet-induced obesity mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Pathogenesis of Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Atopic dermatitis: a disease of altered skin barrier and immune dysregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Dynamics of macrophage polarization reveal new mechanism to inhibit IL-1beta release through pyrophosphates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Cutting edge: reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

The effect of N-acetylcysteine on nuclear factor-κB activation, interleukin-6, interleukin-8, and intercellular adhesion molecule-1 expression in patients with sepsis*

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Glyburide inhibits the Cryopyrin/Nalp3 inflammasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Stimulation of rat erythrocyte P2X7 receptor induces the release of epoxyeicosatrienoic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Sensitivity of a renal K+ channel (ROMK2) to the inhibitory sulfonylurea compound glibenclamide is enhanced by coexpression with the ATP-binding cassette transporter cystic fibrosis transmembrane regulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Hydrogen sulfide augments neutrophil migration through enhancement of adhesion molecule expression and prevention of CXCR2 internalization: role of ATP-sensitive potassium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Glyburide is anti-inflammatory and associated with reduced mortality in melioidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Extracellular ATP is a danger signal activating P2X7 receptor in lung inflammation and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Novel P2X7 receptor antagonists ease the pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

The antihyperalgesic activity of a selective P2X7 receptor antagonist, A-839977, is lost in IL-1alphabeta knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

The challenges of gout management in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Pannexin membrane channels are mechanosensitive conduits for ATP

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Pharmacological characterization of pannexin-1 currents expressed in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Probenecid, a gout remedy, inhibits pannexin 1 channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Anti-IL-1 molecules: new comers and new indications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Pharmacokinetics, safety and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Blocking interleukin-1β in acute and chronic autoinflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Canakinumab for treatment of cryopyrin-associated periodic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

XOMA 052, a potent, high-affinity monoclonal antibody for the treatment of IL-1β-mediated diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Stimulation of Toll-like receptor 3 and 4 induces interleukin-1beta maturation by caspase-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Targeting caspase-1 by inhalation-therapy: effects of Ac-YVAD-CHO on IL-1 beta, IL-18 and downstream proinflammatory parameters as detected in rat endotoxaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Therapeutic application of caspase 1/interleukin-1beta-converting enzyme inhibitor decreases the death rate in severe acute experimental pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Interleukin-1beta converting enzyme (caspase-1) in intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Cryopyrin/NALP3 binds ATP/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

The cytokine release inhibitory drug CRID3 targets ASC oligomerisation in the NLRP3 and AIM2 inflammasomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Glutathione s-transferase omega 1-1 is a target of cytokine release inhibitory drugs and may be responsible for their effect on interleukin-1beta posttranslational processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

NLRP3 inflammasome is a target for development of broad-spectrum anti-infective drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

Unique activation status of peripheral blood mononuclear cells at acute phase of Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.690032

10.1517/13543784.2012.690032

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference